Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet C Lindsey

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Neurosurgical Focus|January 10, 2006
Epigenetic events in medulloblastoma developmentJanet C Lindsey, Jennifer A Anderton, Meryl E Lusher, et al.
Cancer Letters|July 30, 2005
Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymomaDavid W Hamilton, Meryl E Lusher, Janet C Lindsey, et al.
Neuro-Oncology|September 2, 2011
RASSF1A and the BH3-only mimetic ABT-737 promote apoptosis in pediatric medulloblastoma cell linesJane Levesley, Meryl E Lusher, Janet C Lindsey, et al.
Cancer Research|October 18, 2002
Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma developmentMeryl E Lusher, Janet C Lindsey, Farida Latif, et al.
Cancer Genetics and Cytogenetics|July 18, 2006
APC and CTNNB1 mutations are rare in sporadic ependymomasOlabisi E Onilude, Meryl E Lusher, Janet C Lindsey, et al.
Neuro-Oncology|July 31, 2008
Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2Jennifer A Anderton, Janet C Lindsey, Meryl E Lusher, et al.
Cell Cycle (Georgetown, Tex.)|December 19, 2006
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosisSteven C Clifford, Meryl E Lusher, Janet C Lindsey, et al.
International Journal of Cancer|July 29, 2005
Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumoursJanet C Lindsey, Meryl E Lusher, Gordon Strathdee, et al.
Brain Research. Molecular Brain Research|February 19, 2004
The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastomaAdrian J Frank, Roberto Hernan, Andrew Hollander, et al.
Carcinogenesis|December 23, 2003
Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profilingJanet C Lindsey, Meryl E Lusher, Jennifer A Anderton, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Neurosurgical Focus|January 10, 2006
Epigenetic events in medulloblastoma developmentJanet C Lindsey, Jennifer A Anderton, Meryl E Lusher, et al.
Cancer Letters|July 30, 2005
Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymomaDavid W Hamilton, Meryl E Lusher, Janet C Lindsey, et al.
Neuro-Oncology|September 2, 2011
RASSF1A and the BH3-only mimetic ABT-737 promote apoptosis in pediatric medulloblastoma cell linesJane Levesley, Meryl E Lusher, Janet C Lindsey, et al.
Cancer Research|October 18, 2002
Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma developmentMeryl E Lusher, Janet C Lindsey, Farida Latif, et al.
Cancer Genetics and Cytogenetics|July 18, 2006
APC and CTNNB1 mutations are rare in sporadic ependymomasOlabisi E Onilude, Meryl E Lusher, Janet C Lindsey, et al.
Neuro-Oncology|July 31, 2008
Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2Jennifer A Anderton, Janet C Lindsey, Meryl E Lusher, et al.
Cell Cycle (Georgetown, Tex.)|December 19, 2006
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosisSteven C Clifford, Meryl E Lusher, Janet C Lindsey, et al.
International Journal of Cancer|July 29, 2005
Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumoursJanet C Lindsey, Meryl E Lusher, Gordon Strathdee, et al.
Brain Research. Molecular Brain Research|February 19, 2004
The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastomaAdrian J Frank, Roberto Hernan, Andrew Hollander, et al.
Carcinogenesis|December 23, 2003
Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profilingJanet C Lindsey, Meryl E Lusher, Jennifer A Anderton, et al.
Pageof 3